Paladin Advisory Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-13
Closed -$3.41K 282
2022
Q4
$3.41K Hold
13
﹤0.01% 246
2022
Q3
$2K Hold
13
﹤0.01% 256
2022
Q2
$3K Buy
+13
New +$3.19K ﹤0.01% 255
2022
Q1
Sell
-13
Closed -$2K 292
2021
Q4
$2K Buy
+13
New +$2.74K ﹤0.01% 268

Other funds holding AMGN

Paladin Advisory Group's AMGN Position: Q1 2026 in Review

Paladin Advisory Group held its Amgen (AMGN) position steady in Q1 2026 at 13 shares worth $4.57K. The position accounts for ﹤0.01% of the portfolio, ranked #222.

Paladin Advisory Group first reported a position in AMGN in Q1 2022 and has held it in 14 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Paladin Advisory Group held 13 shares of Amgen worth $4.57K as of Q1 2026.
  • Paladin Advisory Group left its Amgen share count unchanged in Q1 2026.
  • Amgen made up ﹤0.01% of Paladin Advisory Group's portfolio in Q1 2026, its #222 holding.
  • Paladin Advisory Group first reported a position in Amgen in Q1 2022 and has held it in 14 quarters since.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Paladin Advisory Group's 13F filing for Q1 2026, filed 30 Apr 2026.